Activation of dopamine D4 receptors is protective against hypoxia/ reoxygenation-induced cell death in HT22 cells

Journal of Pharmacological Sciences

Volumn 114, Issue 2, 2010, Pages 217-224

  Shimada, Saori ^a   Hirabayashi, Mioko ^a   Ishige, Kumiko ^a   Kosuge, Yasuhiro ^a   Kihara, Tetsuro ^a   Ito, Yoshihisa ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Apomorphine; Cell death; Hypoxia reoxygenation; Oxidative stress

Indexed keywords

3 [[4 (4 IODOPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; APOCODEINE; APOMORPHINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; LACTATE DEHYDROGENASE; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT; OXYGEN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL ASSAY; CELL HYPOXIA; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EXPERIMENTAL MODEL; HIPPOCAMPUS; IN VITRO STUDY; INCUBATION TIME; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; REOXYGENATION; ANIMAL; CELL DEATH; CELL LINE; CYTOLOGY; DRUG EFFECT; METABOLISM; NERVE CELL; PHYSIOLOGY; REPERFUSION INJURY; TIME;

ANIMALS; APOMORPHINE; CELL DEATH; CELL HYPOXIA; CELL LINE; DOPAMINE; DOPAMINE AGONISTS; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXYGEN; REACTIVE OXYGEN SPECIES; RECEPTORS, DOPAMINE D4; REPERFUSION INJURY; TIME FACTORS;

EID: 78349301950     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10134FP     Document Type: Article

References (32)

1. Saeed SA, Shad KF, Saleem T, Javed F, Khan MU. Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Exp Brain Res. 2007;182:1-10.
2. Matsuda S, Umeda M, Uchida H, Kato H, Araki T. Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischemia in rats. J Neural Transm. 2009;116:395-404.
3. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation. 2004;109:2357-2362.
4. Meloni BP, Campbell K, Zhu H, Knuckey NW. In search of clinical neuroprotection after brain ischemia: the case for mild hypothermia (35 degrees C) and magnesium. Stroke. 2009;40:2236-2240.
5. Osada N, Kosuge Y, Kihara T, Ishige K, Ito Y. Apolipoprotein E-deficient mice are more vulnerable to ER stress after transient forebrain ischemia. Neurochem Int. 2009;54:403-409.
6. Medling BD, Bueno R, Chambers C, Neumeister MW. The effect of vitamin E succinate on ischemia reperfusion injury. Hand. 2009;5:60-64.
7. Hashimoto T, Yonetani M, Nakamura H. Selective brain hypothermia protects against hypoxic-ischemic injury in newborn rats by reducing hydroxyl radical production. Kobe J Med Sci. 2003; 49:83-91.
8. Dhar-Mascareno M, Carcamo JM, Golde DW. Hypoxia-reoxygenation- induced mitochondrial damage and apoptosis in human endothelial cells are inhibited by vitamin C. Free Radic Biol Med. 2005;38:1311-1322.
9. Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke. 2005;36:2220-2225.
10. Kawai H, Nakai H, Suga M, Yuki S, Watanabe T, Saito KI. Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther. 1997;281:921-927.
11. Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke. 1988;19:480-485.
12. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612-1623.
13. Zong XM, Sun YF, Pei DS, Zeng YM, Xu T. Pergolide protects CA1 neurons from apoptosis in a gerbil model of global cerebral ischemia. Neurol Res. 2008;30:92-98.
14. Zhang Y, Deng P, Ruan Y, Xu ZC. Dopamine D1-like receptors depress excitatory synaptic transmissions in striatal neurons after transient forebrain ischemia. Stroke. 2008;39:2370-2376.
15. Narkar V, Kunduzova O, Hussain T, Cambon C, Parini A, Lokhandwala M. Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney. Kidney Int. 2004;66:633-640.
16. Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994;15:264-270.
17. Khaliulin I, Schneider A, Houminer E, Borman JB, Schwalb H. Apomorphine prevents myocardial ischemia/reperfusion-induced oxidative stress in the rat heart. Free Radic Biol Med. 2004;37: 969-976.
18. Khaliulin I, Schneider A, Houminer E, Borman JB, Schwalb H. Apomorphine-induced myocardial protection is due to antioxidant and not adrenergic/dopaminergic effects. Free Radic Biol Med. 2006;40:1713-1720.
19. Ishige K, Chen Q, Sagara Y, Schubert D. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. J Neurosci. 2001;21:6069-6076.
20. Okada Y, Sakai H, Kohiki E, Suga E, Yanagisawa Y, Tanaka K, et al. A dopamine D4 receptor antagonist attenuates ischemiainduced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. J Cereb Blood Flow Metab. 2005;25: 794-806.
21. Hanson ES, Leibold EA. Regulation of iron regulatory protein 1 during hypoxia and hypoxia/reoxygenation. J Biol Chem. 1998; 273:7588-7593.
22. Tamatani M, Mitsuda N, Matsuzaki H, Okado H, Miyake S, Vitek MP, et al. A pathway of neuronal apoptosis induced by hypoxia/ reoxygenation: roles of nuclear factor-kappaB and Bcl-2. J Neurochem. 2000;75:683-693.
23. Kosuge Y, Koen Y, Ishige K, Minami K, Urasawa H, Saito H, et al. S-allyl-L-cysteine selectively protects cultured rat hippocampal neurons from amyloid beta-protein- and tunicamycininduced neuronal death. Neuroscience. 2003;122:885-895.
24. Levraut J, Iwase H, Shao ZH, Van den Hoek TL, Schumacker PT. Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol. 2003;284:H549-H558.
25. Patel S, Patel S, Marwood R, Emms F, Marston D, Leeson PD, et al. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor. Mol Pharmacol. 1996;50:1658-1664.
26. Bowery BJ, Razzaque Z, Emms F, Patel S, Freedman S, Bristow L, et al. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626. Br J Pharmacol. 1996;119:1491-1497.
27. Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, et al. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther. 1995;275:1239-1246.
28. Matulenko MA, Hakeem AA, Kolasa T, Nakane M, Terranova MA, Uchic ME, et al. Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl) acetamides: selective dopamine D4 receptor agonists. Bioorg Med Chem. 2004;12: 3471-3483.
29. Tan S, Sagara Y, Liu Y, Maher P, Schubert D. The regulation of reactive oxygen species production during programmed cell death. J Cell Biol. 1998;141:1423-1432.
30. Tan S, Wood M, Maher P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J Neurochem. 1998;71:95-105.
31. Li Y, Maher P, Schubert D. Requirement for cGMP in nerve cell death caused by glutathione depletion. J Cell Biol. 1997;139: 1317-1324.
32. Ishimura A, Ishige K, Taira T, Shimba S, Ono S, Ariga H, et al. Comparative study of hydrogen peroxide- and 4-hydroxy-2- nonenal-induced cell death in HT22 cells. Neurochem Int. 2008; 52:776-785.